pluripotent stem cell-derived mesenchymal stem cell exosome (Zhejiang University/Hangzhou yuansheng biotechnology)

N/A

Report date: 2025/03/20 14:43:14

Base Information

Drug Namepluripotent stem cell-derived mesenchymal stem cell exosome (Zhejiang University/Hangzhou yuansheng biotechnology)
Drug Alias NamePSC-MSC-Exo
ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Qiansheng Biotechnology Co LtdZhejiang University
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A